NRXS

AMEX:NRXS

NeurAxis, Inc.

  • Stock

USD

Last Close

3.12

26/07 19:58

Market Cap

20.74M

Beta: -

Volume Today

1.47K

Avg: 14.56K

PE Ratio

−0.87

PFCF: −2.71

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suff...Show More

peer of

Earnings

Earnings per Share (Estimate*)

-1.2-1-0.8-0.6-0.4-0.22021-12-312022-06-302022-12-312023-08-182023-11-20

Revenue (Estimate*)

500K1M1.50M2M2.50M2021-12-312022-06-302022-12-312023-08-182023-11-20

*Estimate based on analyst consensus